Publications - 'O'
Publications 551 - 575 de 1113
| Titre | DOI |
|---|---|
|
Operational leeway in work situations: do ergonomic risk assessment tools consider operational leeway for job analysis? M. Norval; M. Zare; R. Brunet; F. Coutarel; Y. Roquelaure 2019 |
10.1080/10803548.2017.1387392 |
|
Operationalising the ``One Health'' approach in India: facilitators of and barriers to effective cross-sector convergence for zoonoses prevention and control F.A. Asaaga; J.C. Young; M.A. Oommen; R. Chandarana; J. August; J. Joshi; M.M. Chanda; A.T. Vanak; P.N. Srinivas; S.L. Hoti; T. Seshadri; 2021 |
10.1186/s12889-021-11545-7 |
|
OPERATIONS ON POLYCHAINS G. Massuyeau; V. Turaev 2017 |
|
|
Operator biflatness of the L-1-algebras of compact quantum groups M. Caspers; H.Hee Lee; E. Ricard 2015 |
10.1515/crelle-2013-0016 |
|
OPERATOR-VALUED LOCAL HARDY SPACES R. Xia; X. Xiong 2019 |
10.7900/jot.2018jun02.2191 |
|
Operator-Valued Triebel-Lizorkin Spaces R. Xia; X. Xiong 2018 |
10.1007/s00020-018-2491-1 |
|
Ophthalmic epidemiology in Europe: the ``European Eye Epidemiology'' (E3) consortium C. Delcourt; J.F. Korobelnik; G.H.S. Buitendijk; P.J. Foster; C.J. Hammond; S. Piermarocchi; T. Peto; N. Jansonius; A. Mirshahi; R.E. Hogg; L. Bretillon; F. Topouzis; G. Deak; J. Grauslund; R. Broe; E.H. Souied; C. Creuzot-Garcher; J. Sahel; V. Daien; T. Lehtimaki; H.W. Hense; E. Prokofyeva; K. Oexle; J.S. Rahi; P.M. Cumberland; S. Schmitz-Valckenberg; S. Fauser; G. Bertelsen; C. Hoyng; A. Bergen; R. Silva; S. Wolf; A. Lotery; U. Chakravarthy; A. Fletcher; C.C.W. Klaver 2016 |
10.1007/s10654-015-0098-2 |
|
Ophthalmic manifestations in IgG4-related disease Clinical presentation and response to treatment in a French case-series M. Ebbo; M. Patient; A. Grados; M. Groh; J. Desblaches; E. Hachulla; D. Saadoun; S. Audia; A. Rigolet; B. Terrier; A. Perlat; C. Guillaud; F. Renou; E. Bernit; N. Costedoat-Chalumeau; J.R. Harle; N. Schleinitz 2017 |
10.1097/MD.0000000000006205 |
|
Ophthalmic Outcomes of Congenital Toxoplasmosis Followed Until Adolescence M. Wallon; J.G. Garweg; M. Abrahamowicz; C. Cornu; S. Vinault; C. Quantin; C. Bonithon-Kopp; S. Picot; F. Peyron; C. Binquet 2014 |
10.1542/peds.2013-2153 |
|
OPHTHALMOLOGICAL ADVERSE EVENTS UNDER JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS: CASE ANALYSIS OF THE EUROPEAN PHARMACOVIGILANCE DATABASE S. Hecquet; M.Blanche Rabier; M. Lepelley; F. Verhoeven; A.Sophie Gauthier; C. Prati; B. Delbosc; D. Wendling 2019 |
10.1136/annrheumdis-2019-eular.3811 |
|
Opinion on cancer screening: Impact on prescription and participation rates J.F. Morere; J. Viguier; S. Couraud; L. Guibaudet; J.Y. Blay; A.B. Cortot; C. Lhomel; L. Greillier; X. Pivot; F. Eisinger 2016 |
10.1093/annonc/mdw385.4 |
|
Opioid switch and change of route of administration in cancer patients treated by morphine N. Michenot; S. Rostaing; L. Baron; S. Faure; N. Jovenin; P. Hubault; T. Delorme; E. Collin; M. Filbet; G. Chvetzoff; C. Delorme; C. Minello; M. Magnet; D. Ammar; I. Krakowski; P. Poulain 2018 |
10.1016/j.bulcan.2018.06.011 |
|
Opioids in cancer-related pain: current situation and outlook B. George; C. Minello; G. Allano; C. Maindet; A. Burnod; A. Lemaire 2019 |
10.1007/s00520-019-04828-8 |
|
Opportunistic behaviors in green signaling: When do firms engage in symbolic green product preannouncement? Y. Truong; J. Pinkse 2019 |
10.1016/j.ijpe.2019.06.015 |
|
Opportunities and Challenges of Fluorescent Carbon Dots in Translational Optical Imaging J. Wang; G. Liu; K.ChamFai Leung; R. Loffroy; P.X. Lu; Y.Xiang J. Wang 2015 |
10.2174/1381612821666150917093232 |
|
Opportunity costs resulting from scramble competition within the choosy sex severely impair mate choosiness F.X. Dechaume-Moncharmont; T. Brom; F. Cezilly 2016 |
10.1016/j.anbehav.2016.02.019 |
|
Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth H. Zheng; W. Zou; J. Shen; L. Xu; S. Wang; Y.X. Fu; W. Fan 2016 |
10.5966/sctm.2015-0300 |
|
Opposite effects of hypertension and physical exercise on cerebrovascular BDNF levels A. Monnier; A. Quirie; P. Garnier; C. Demougeot; C. Marie; A. Prigent-Tessier 2016 |
|
|
Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders S. Barbosa; S. Greville-Heygate; M. Bonnet; A. Godwin; C. Fagotto-Kaufmann; ; D. Laouteouet; R. Mawby; H.Aung Wai; A.J.M. Dingemans; J. Hehir-Kwa; M. Willems; Y. Capri; S.G. Mehta; H. Cox; D. Goudie; F. Vansenne; P. Turnpenny; M. Vincent; B. Cogne; G. Lesca; J. Hertecant; D. Rodriguez; B. Keren; L. Burglen; M. Gerard; A. Putoux; V. Cantagrel; K. Siquier-Pernet; M. Rio; S. Banka; A. Sarkar; M. Steeves; M. Parker; E. Clement; S. Moutton; F.Tran Mau-Them; A. Piton; B.B.A. de Vries; M. Guille; A. Debant; S. Schmidt; D. Baralle; C.4R.C.D.Res Grp 2020 |
10.1016/j.ajhg.2020.01.018 |
|
Opposition to health care in dementia: Pregabalin can be useful to facilitate the management R. Bardet 2015 |
10.1016/j.lpm.2015.04.030 |
|
Opsoclonus and Neuroborreliosis Can't See the Forest for the Trees M. Sauvant; Q. Thomas; S. Mohr; C. Blanc-Labarre; Y. Bejot; B. Delpont 2021 |
10.1212/CPJ.0000000000000824 |
|
OPTEER, adevice of knowledge and territorial analysis by and for the actors of energy transition M.H. de Sede-Marceau; S. Francois; B. Pauc 2018 |
10.3166/rig.2017.00040 |
|
Optic neuritis related to tumor necrosis factor-alpha antagonists: description of 30 cases in a nationwide pharmacovigilance database M.A. Laville; B. Mosquet; C. Breuilly; M. Cohen; A. Fromont; H. Zephyr; A. Coquerel; G. Defer; N. Derache 2015 |
|
|
Optic neuritis related to tumor necrosis factor-alpha antagonists: description of 30 cases in a nationwide pharmacovigilance database M.A. Laville; B. Mosquet; C. Breuilly; M. Cohen; A. Fromont; H. Zephyr; A. Coquerel; G. Defer; N. Derache 2015 |
|
|
Optic neuritis related to tumour necrosis factor-a antagonists: description of 30 cases in a nationwide pharmacovigilance database M.A. Laville; B. Mosquet; C. Breuilly; M. Cohen; A. Fromont; H. Zephir; A. Coquerel; G. Defer; N. Derache 2014 |